Researchers at the University of British Columbia Okanagan have published a mathematical argument that, they say, rules out ...

AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for ...

According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Newly available videos and existing footage synchronized and assessed by The Times provide a frame-by-frame look at how an ICE officer ended up shooting and killing a motorist in Minneapolis. By The ...

TikTok’s algorithm favors mental health content over many other topics, including politics, cats and Taylor Swift, according to a Washington Post analysis. At first, the mental health-related videos ...

Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares are volatile on Tuesday following the release of the company’s second-quarter financial results. Here’s what you need to know. RXRX is hovering near ...